Could a wearable sensor replace Finger-Sticks for hospital diabetes care?

NCT ID NCT04845685

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests whether a continuous glucose monitor (CGM) worn on the skin can accurately track blood sugar levels in hospitalized patients with diabetes who have just had major transplant surgery. The CGM measures glucose every 1-5 minutes, and researchers compare its readings to standard finger-stick tests. The goal is to see if the device is reliable enough to help prevent dangerous blood sugar highs and lows in a hospital setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Continuous Glucose Monitor (CGM) device (Dexcom G6 PRO)
What this could lead to
If successful, this could show that CGMs are reliable enough to replace frequent finger-stick tests in hospitalized patients, potentially improving safety and reducing nursing workload.
What could go wrong
This is a small, early-stage accuracy study, not a large trial testing patient outcomes. The device may not perform as well in sick, post-surgery patients as it does in outpatient settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic in Florida

    Jacksonville, Florida, 32224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.